These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more. Scheifele DW, Bjornson GJ. CMAJ; 1993 Feb 15; 148(4):551-5. PubMed ID: 8431816 [Abstract] [Full Text] [Related]
7. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children. Lee CY, Huang LM, Lee PI, Chiu HH, Dumas R, Milcamps B, Lin W. Southeast Asian J Trop Med Public Health; 2000 Mar 15; 31(1):29-36. PubMed ID: 11023061 [Abstract] [Full Text] [Related]
9. A two dose combined hepatitis A and B vaccine in Chinese youngsters. Lee SD, Chan CY, Yu MI, Wang YJ, Chang FY, Lo KJ, Safary A. J Med Virol; 1999 Sep 15; 59(1):1-4. PubMed ID: 10440800 [Abstract] [Full Text] [Related]
15. Safety and effectiveness of the new inactivated hepatitis A virus vaccine. Furesz J, Scheifele DW, Palkonyay L. CMAJ; 1995 Feb 01; 152(3):343-8. PubMed ID: 7828098 [Abstract] [Full Text] [Related]